新入荷
再入荷
32971-X/asset/9b996016-dd72-4ddd-a43d-473a0a0c00d4/main.assets/gr2_lrg.jpg "Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer | New England Journal of Medicine")
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer | New England Journal of Medicine
4
（1件）
タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料（※）
999円以上お買上げで代引き手数料無料
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
商品詳細情報
| 管理番号 | 中古 ：18619152219 | メーカー | d8ef268e7a | 発売日 | 2025-04-10 10:42 | 定価 | 15000円 | ||
|---|---|---|---|---|---|---|---|---|---|
| カテゴリ | |||||||||
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer | New England Journal of Medicine
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer | New England Journal of Medicine,First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial -,Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study | Blood Cancer Journal,Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial - The Lancet,Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials | Nature Medicine
健康・医学の作品リスト
レディースの製品
